Demographics, innovative outputs and alliance strategies of Canadian biotech firms

This paper focuses on the characteristics of biotech firms that consider alliances as critical to the innovation and commercialization of biotech-based products. First, we consider alliances with both universities and industries. Next, we examine attributes for those firms who consider proximity to universities as critical compared with others that do not put high value on physical proximity. Our study is informed by the literature on the biotechnology industry as well as studies on absorptive capacity, alliances and clusters in exploration and exploitation of knowledge, research and technologies. We analyse data based on a 2002 survey of Canadian biotech firms and find that while collaborative arrangements with universities are the most common among our sample firms, those who assign a high value to such linkages are not necessarily always the biotech firms experiencing commercial success.